Clinical trial
Vulvar Vestibulitis Clinical Trial: Desipramine-Lidocaine
NCT00276068 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00276068 |
|---|---|
| Title | Vulvar Vestibulitis Clinical Trial: Desipramine-Lidocaine |
| Official title | Vulvar Vestibulitis Trial: Desipramine-Lidocaine |
| Lead sponsor | University of Rochester, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Vulvar Disease |
| Intervention type | Drug |
| Interventions | topical lidocaine + oral desipramine, and/or placebo |
| Enrollment | 128 |
| Start date | Aug 1, 2002 |
| Completion | Sep 1, 2007 |
| First posted | Jan 12, 2006 |
| Last update posted | Nov 14, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: